Cyclin E-CDK2

Definition

Cyclin E-CDK2 is a complex formed by the regulatory protein cyclin E and the cyclin-dependent kinase CDK2, crucial for the control of the cell cycle, particularly in the transition from the G1 phase to the S phase. This complex drives the progression into DNA synthesis by phosphorylating target proteins that facilitate cell cycle progression, thereby ensuring that cells only replicate their DNA when they are ready.

5 Must Know Facts For Your Next Test

1. Cyclin E is synthesized in response to growth signals and accumulates during the G1 phase, setting the stage for its interaction with CDK2.
2. The cyclin E-CDK2 complex is responsible for phosphorylating retinoblastoma protein (Rb), leading to the release of E2F transcription factors that promote S phase entry.
3. Dysregulation of cyclin E-CDK2 activity can lead to uncontrolled cell proliferation and is often implicated in various cancers.
4. The activity of CDK2 is regulated by cyclin-binding and phosphorylation, ensuring precise timing of cell cycle transitions.
5. Inhibitors such as p27^kip1 can bind to and inhibit cyclin E-CDK2, providing a checkpoint mechanism that prevents premature entry into the S phase.

Review Questions

• How does cyclin E-CDK2 contribute to the progression of the cell cycle from G1 to S phase?
  • Cyclin E-CDK2 plays a pivotal role in transitioning the cell from G1 to S phase by phosphorylating key substrates like the retinoblastoma protein (Rb). This phosphorylation releases E2F transcription factors that initiate the expression of genes required for DNA synthesis. Without this activation, cells would be unable to progress efficiently into S phase, which is crucial for proper cell division.
• What mechanisms regulate the activity of cyclin E-CDK2, and why is this regulation important?
  • The activity of cyclin E-CDK2 is primarily regulated through cyclin binding and phosphorylation events. Cyclin E levels rise in response to growth signals, while specific phosphorylation events can activate or inhibit CDK2. This regulation is crucial because it ensures that cells do not prematurely enter S phase, preventing potential errors in DNA replication that could lead to mutations or cancerous growth.
• Discuss the implications of aberrant cyclin E-CDK2 signaling in cancer development and treatment strategies.
  • Aberrant signaling of cyclin E-CDK2 has significant implications for cancer development as overexpression or dysregulation can lead to uncontrolled cell proliferation. This has led researchers to explore therapeutic strategies that target this pathway, aiming to inhibit its activity in tumor cells. By understanding how cyclin E-CDK2 contributes to malignancy, new treatment options such as CDK inhibitors are being developed to selectively halt cancer progression while sparing normal cells.

Related terms

Cell Cycle: The series of events that cells go through as they grow and divide, consisting of phases including G1, S, G2, and M.

CDK (Cyclin-Dependent Kinase): A family of protein kinases that are essential for regulating the cell cycle, activated by binding to cyclins.

Phosphorylation:

The process of adding a phosphate group to a protein or other organic molecule, which can modify its function and activity.